2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$4.48-$0.15 (-3.26%)
Price as of Jun 03, 2026 7:58 PM EDT- $635.5MMarket Cap
- 214.97%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$4.48-$0.15 (-3.26%)
ACRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.63 | ||
Change | +$0.29 (+6.68%) | ||
Open | $4.41 | ||
High | $4.67 | ||
Low | $4.35 | ||
Previous Close | $4.34 | ||
Volume | 1,510,174 | ||
30-Day Average Volume | 1,218,435 | ||
1-Week Change | 2.66% | ||
1-Month Change | 4.99% | ||
1-Year Change | 214.97% | ||
3-Year Change | -47.33% | ||
5-Year Change | -78.70% | ||
Fundamentals | |||
Shares Outstanding | 139.7M | ||
Total Assets | $198.7M | ||
Market Cap | $635.5M | ||
Enterprise Value | $606.8M | ||
Period: QTR TTM FY | |||
Revenue | $537,000.00 | ||
Net Income | -$19.8M | ||
Free Cash Flow | -$18.2M | ||
EBIT | -$19.8M | ||
EBITDA | -$19.7M | ||
Net Working Capital | $82.9M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 1,130 | ||
P/B | 4 | ||
P/E | -30 | ||
PEG | -4 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue